CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Acetaminophen

对乙酰氨基酚 杂质对照品Acetaminophen Impurities

EP48 个杂质条目48 impurity entries

本页汇总 对乙酰氨基酚 的 48 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 48 impurity reference standards of Acetaminophen with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 对乙酰氨基酚(Acetaminophen)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesQuantitative analysis of related substances in acetaminophen tablets using pre-column derivatization coupled with HPLC-ICP-MS
    Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025 · Liu Y et al.  ·  PMID 40025270  ·  DOI
  2. 杂质研究Impurity studiesBioremediation of emerging pharmaceutical pollutants acetaminophen and ibuprofen by white-rot fungi - A review
    The Science of the total environment · 2025 · Flórez-Restrepo MA et al.  ·  PMID 40239505  ·  DOI
  3. 分析方法Analytical MethodsAn effective and stability-indicating method development and optimization utilizing the Box-Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation
    Biomedical chromatography : BMC · 2023 · Yenda P et al.  ·  PMID 36692333  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisRapid synthesis of a hybrid of rGO/AuNPs/MWCNTs for sensitive sensing of 4-aminophenol and acetaminophen simultaneously
    Analytical and bioanalytical chemistry · 2021 · Dou N, Qu J  ·  PMID 32783127  ·  DOI
  • 合成方法SynthesisAcetaminophen inhibits diacylglycerol lipase synthesis of 2-arachidonoyl glycerol: Implications for nociception
    Cell reports. Medicine · 2025 · Dvorakova M et al.  ·  PMID 40381619  ·  DOI

对乙酰氨基酚 —— 原料药与杂质对照品Acetaminophen — drug substance & impurities

共 49 个条目(含原料药本体)49 items incl. the drug substance
Acetaminophen Sulphate Potassium Salt structure
EP原料药 APIAPI
对乙酰氨基酚Acetaminophen Sulphate Potassium Salt
Acetaminophen Sulphate Potassium Salt
CAS No.32113-41-0
Chemical FormulaC8H8KNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity A (Acetaminophen USP Related Compound C) structure
EPA
Paracetamol EP Impurity A (Acetaminophen USP Related Compound C)
CAS No.614-80-2
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity B (Acetaminophen USP Related Compound B) structure
EPB
Paracetamol EP Impurity B (Acetaminophen USP Related Compound B)
CAS No.1693-37-4
Chemical FormulaC9H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity C structure
EPC
Paracetamol EP Impurity C
CAS No.3964-54-3
Chemical FormulaC8H8ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity D (Acetaminophen USP Related Compound D) structure
EPD
Paracetamol EP Impurity D (Acetaminophen USP Related Compound D)
CAS No.103-84-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity F (Acetaminophen USP Related Compound F) structure
EPF
Paracetamol EP Impurity F (Acetaminophen USP Related Compound F)
CAS No.100-02-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity G structure
EPG
Paracetamol EP Impurity G
CAS No.34523-34-7
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity H (Acetaminophen USP Related Compound A) structure
EPH
Paracetamol EP Impurity H (Acetaminophen USP Related Compound A)
CAS No.2623-33-8
Chemical FormulaC10H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity I structure
EPI
Paracetamol EP Impurity I
CAS No.118-93-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity J (Acetaminophen USP Related Compound J) structure
EPJ
Paracetamol EP Impurity J (Acetaminophen USP Related Compound J)
CAS No.539-03-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity L structure
EPL
Paracetamol EP Impurity L
CAS No.2514961-29-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity M HCl structure
EPM
Paracetamol EP Impurity M HCl
CAS No.1965310-24-0
Chemical FormulaC12H12ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Paracetamol EP Impurity M structure
EPM
N-Nitroso Paracetamol EP Impurity M
CAS No.—
Chemical FormulaC12H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity N structure
EPN
Paracetamol EP Impurity N
CAS No.3070-86-8
Chemical FormulaC16H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Paracetamol EP Impurity O structure
EPO
Paracetamol EP Impurity O
CAS No.2575516-61-7
Chemical FormulaC16H16N2O4
Purity>95%询价On request
10mg25mg50mg100mg
(S)-3-Cysteinyl Acetaminophen structure
—
(S)-3-Cysteinyl Acetaminophen
CAS No.119738-55-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Glucuronide Sodium Salt (Paracetamol Glucuronide Sodium Salt) structure
—
Acetaminophen Glucuronide Sodium Salt (Paracetamol Glucuronide Sodium Salt)
CAS No.120595-80-4
Chemical FormulaC14H16NNaO8
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Acetaminophen structure
—
N-Nitroso Acetaminophen
CAS No.146897-60-1
Chemical FormulaC8H8N2O3
Purity>95%询价On request
10mg25mg50mg100mg
3-Hydroxyacetaminophen structure
—
3-Hydroxyacetaminophen
CAS No.37519-14-5
Chemical FormulaC8H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Mercapturate structure
—
Acetaminophen Mercapturate
CAS No.52372-86-8
Chemical FormulaC13H16N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
3-Cysteinyl Acetaminophen structure
—
3-Cysteinyl Acetaminophen
CAS No.53446-10-9
Chemical FormulaC11H14N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Dimer (Paracetamol Dimer) structure
—
Acetaminophen Dimer (Paracetamol Dimer)
CAS No.98966-14-4
Chemical FormulaC16H16N2O4
Purity>95%询价On request
10mg25mg50mg100mg
3-Hydroxyacetaminophen-d3 structure
—
3-Hydroxyacetaminophen-d3
CAS No.—
Chemical FormulaC8H6D3NO3
Purity>95%询价On request
3-Cysteinyl Acetaminophen HCl structure
—
3-Cysteinyl Acetaminophen HCl
CAS No.—
Chemical FormulaC11H14N2O4S.HCl
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Acetaminophen-d3 structure
—
N-Nitroso Acetaminophen-d3
CAS No.—
Chemical FormulaC8H5D3N2O3
Purity>95%询价On request
Acetaminophen-d3 Mercapturate structure
—
Acetaminophen-d3 Mercapturate
CAS No.—
Chemical FormulaC11H11D3N2O4S
Purity>95%询价On request
Acetamidophen Glucuronide-13C6 structure
—
Acetamidophen Glucuronide-13C6
CAS No.—
Chemical FormulaC813C6H17NO8
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 1 structure
1
对乙酰氨基酚杂质1Acetaminophen Impurity 1
Acetaminophen Impurity 1
CAS No.2819093-06-4
Chemical FormulaC16H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 2 structure
2
对乙酰氨基酚杂质2Acetaminophen Impurity 2
Acetaminophen Impurity 2
CAS No.2518359-40-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 3 Disodium Salt structure
3
对乙酰氨基酚杂质3Acetaminophen Impurity 3 Disodium Salt
Acetaminophen Impurity 3 Disodium Salt
CAS No.—
Chemical FormulaC18H22N4O8S.2Na
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 5 HCl structure
5
对乙酰氨基酚杂质5Acetaminophen Impurity 5 HCl
Acetaminophen Impurity 5 HCl
CAS No.—
Chemical FormulaC14H14N2O2.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 6 structure
6
对乙酰氨基酚杂质6Acetaminophen Impurity 6
Acetaminophen Impurity 6
CAS No.55748-93-1
Chemical FormulaC13H16N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 7 (4-quinoneimine) structure
7
甲苯磺酸索拉非尼杂质45Acetaminophen Impurity 7 (4-quinoneimine)
Acetaminophen Impurity 7 (4-quinoneimine)
CAS No.3009-34-5
Chemical FormulaC6H5NO
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 8 structure
8
对乙酰氨基酚杂质8Acetaminophen Impurity 8
Acetaminophen Impurity 8
CAS No.98966-17-7
Chemical FormulaC16H16N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 9 structure
9
对乙酰氨基酚杂质9Acetaminophen Impurity 9
Acetaminophen Impurity 9
CAS No.100-00-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 10 (2-Chloroacetanilide) structure
10
双氯芬酸钠杂质24Acetaminophen Impurity 10 (2-Chloroacetanilide)
Acetaminophen Impurity 10 (2-Chloroacetanilide)
CAS No.587-65-5
Chemical FormulaC8H8ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 11 structure
11
对乙酰氨基酚杂质11Acetaminophen Impurity 11
Acetaminophen Impurity 11
CAS No.801215-24-7
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 12 structure
12
对乙酰氨基酚杂质12Acetaminophen Impurity 12
Acetaminophen Impurity 12
CAS No.1374027-64-1
Chemical FormulaC15H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 13 structure
13
对乙酰氨基酚杂质13Acetaminophen Impurity 13
Acetaminophen Impurity 13
CAS No.—
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 14 structure
14
对乙酰氨基酚杂质14Acetaminophen Impurity 14
Acetaminophen Impurity 14
CAS No.1991204-56-8
Chemical FormulaC16H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 15 structure
15
对乙酰氨基酚杂质15Acetaminophen Impurity 15
Acetaminophen Impurity 15
CAS No.—
Chemical FormulaC16H16N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 16 structure
16
对乙酰氨基酚杂质16Acetaminophen Impurity 16
Acetaminophen Impurity 16
CAS No.—
Chemical FormulaC17H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 17 structure
17
对乙酰氨基酚杂质17Acetaminophen Impurity 17
Acetaminophen Impurity 17
CAS No.2130910-69-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 18 structure
18
对乙酰氨基酚杂质18Acetaminophen Impurity 18
Acetaminophen Impurity 18
CAS No.—
Chemical FormulaC17H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 19 structure
19
对乙酰氨基酚杂质19Acetaminophen Impurity 19
Acetaminophen Impurity 19
CAS No.—
Chemical FormulaC12H13NO7
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 20 structure
20
对乙酰氨基酚杂质20Acetaminophen Impurity 20
Acetaminophen Impurity 20
CAS No.—
Chemical FormulaC12H13NO7
Purity>95%询价On request
10mg25mg50mg100mg
Acetaminophen Impurity 21 structure
21
对乙酰氨基酚杂质21Acetaminophen Impurity 21
Acetaminophen Impurity 21
CAS No.13871-68-6
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

对乙酰氨基酚 —— 研究文献与合成路线Acetaminophen — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 对乙酰氨基酚 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Acetaminophen. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Functional Characterization and Catalytic Mechanism of an Amidase Involved in Acetaminophen Degradation from Acinetobacter sp
    Kou B, Yue Y, Wang L, et al. · Journal of agricultural and food chemistry · 2026
  2. Galangin Ameliorates Acetaminophen-Induced Acute Liver Injury by Inhibiting Ferroptosis through the Prevention of Chaperone-Mediated Autophagic Degradation of FTH1
    Li J, Lu W, Zhang Z, et al. · Journal of agricultural and food chemistry · 2026
  3. Targeted Degradation of Prolyl Hydroxylase Domain Enzyme 1 (PHD1) as a Novel Therapeutic Strategy for Acetaminophen-Induced Acute Liver Injury
    Su H, Li Y, Xie T, et al. · Journal of medicinal chemistry · 2026
  4. Peroxide-driven activation on NH2 and graphitic-N doped rice-residue carbon for e−/h+ mediated degradation of acetaminophen and diclofenac
    Crestani L, Abreu Teles C, Carvalho Collazzo G, et al. · Chemosphere · 2025
  5. Effects of Manganese Carbonate Addition on the Carbocatalytic Properties of Lignocellulosic Waste for Use in the Degradation of Acetaminophen
    Mosquera-Olano C, Quimbaya C, Rodríguez V, et al. · Polymers · 2024
  6. An effective and stability-indicating method development and optimization utilizing the Box-Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation
    Yenda P, Katari NK, Ettaboina SK, et al. · Biomedical chromatography : BMC · 2023 · 被引 14cited 14

合成与制备工艺专利Synthesis & process patents

  1. REACTIVE DISTILLATION PROCESS FOR PREPARATION OF ACETAMINOPHEN
    KRISHNA BHASKAR ARUMUGAM, ABUL HASNAT, SIRISHA PAMIDIPATI · 公开号 US2012065423US2012065423 · 2012
  2. Method for processing acetaminophen refined mother liquid
    YUANHAI YAO, JINGWEI CHEN · 公开号 CN101624352CN101624352 · 2010
  3. DRUG PREPARATION OF TRAMADOL AND ACETAMINOPHEN
    KUGELMANN HEINRICH · 公开号 WO2008064854WO2008064854 · 2008
  4. ACETAMINOPHEN OF PULMONARY INHALATION POWDERS AND METHOD FOR PREPARING THE SAME
    SONG CHI SUNG, SONG CHAN HO, LEE KWANG GEUN, HER JAE YOUNG · 公开号 KR20100032116KR20100032116 · 2010
  5. ACETAMINOPHEN FINE PARTICLE USING SUPERCRITICAL AND SUBCRITICAL FLUID PROCESS AND A MANUFACTURING PROCESS THEREOF
    LEE YOUN WOO, CHU JUN HO, LI GUANGHUA, ROW KYUNG HO · 公开号 KR100881407BKR100881407B · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

对乙酰氨基酚 杂质谱研究要点Acetaminophen — impurity profiling notes

下面这些是拿到 对乙酰氨基酚 的 49 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 49 impurity entries for Acetaminophen, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances